Electrocore Inc (ECOR)

$15.90 +0.20 (1.27%)
Market Cap 102.91M
Revenue (ttm) 16.03M
Net Income (ttm) -18.83M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -117.47%
Debt to Equity Ratio 0.00
Volume 200,700
Avg Vol 131,506
Day's Range N/A - N/A
Shares Out 6.56M
Stochastic %K 40%
Beta 0.50
Analysts Strong Sell
Price Target $26.75

Latest News on ECOR

electroCore: An Opportunity In Medical And Wellness Device Innovation

Jan 14, 2025, 10:17 AM EST - 3 days ago

electroCore: An Opportunity In Medical And Wellness Device Innovation

electroCore Has Only Just Begun To Scratch The Surface Of Its Huge TAM

Dec 30, 2024, 1:59 PM EST - 18 days ago

electroCore Has Only Just Begun To Scratch The Surface Of Its Huge TAM

electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness

Dec 17, 2024, 4:05 PM EST - 4 weeks ago

electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness

electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21

Nov 14, 2024, 8:00 AM EST - 2 months ago

electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21

electroCore, Inc. (ECOR) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 9:18 PM EST - 2 months ago

electroCore, Inc. (ECOR) Q3 2024 Earnings Call Transcript

electroCore Announces Third Quarter 2024 Financial Results

Nov 13, 2024, 4:01 PM EST - 2 months ago

electroCore Announces Third Quarter 2024 Financial Results

ElectroCore's Truvaga™ Plus Wins Men's Health Magazine Tech Award

Nov 12, 2024, 4:01 PM EST - 2 months ago

ElectroCore's Truvaga™ Plus Wins Men's Health Magazine Tech Award

electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

Nov 8, 2024, 4:01 PM EST - 2 months ago

electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

electroCore to Participate at LD Micro Main Event VXII

Oct 14, 2024, 8:00 AM EDT - 3 months ago

electroCore to Participate at LD Micro Main Event VXII

Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effective in accelerating United States Air Force Pilot Training

Sep 10, 2024, 8:00 AM EDT - 4 months ago

Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effective in accelerating United States Air Force Pilot Training

electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Sep 4, 2024, 8:00 AM EDT - 4 months ago

electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

electroCore, Inc. (ECOR) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 4:27 AM EDT - 5 months ago

electroCore, Inc. (ECOR) Q2 2024 Earnings Call Transcript

electroCore to Participate in Upcoming Investor Conferences

Aug 8, 2024, 8:00 AM EDT - 5 months ago

electroCore to Participate in Upcoming Investor Conferences

electroCore Announces Second Quarter 2024 Financial Results

Aug 7, 2024, 4:01 PM EDT - 5 months ago

electroCore Announces Second Quarter 2024 Financial Results

electroCore Announces the Commercial Launch of TAC-STIM™

Jun 25, 2024, 8:00 AM EDT - 7 months ago

electroCore Announces the Commercial Launch of TAC-STIM™

electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules

Jun 3, 2024, 8:30 AM EDT - 8 months ago

electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules

electroCore, Inc. (ECOR) Q1 2024 Earnings Call Transcript

May 8, 2024, 10:19 PM EDT - 9 months ago

electroCore, Inc. (ECOR) Q1 2024 Earnings Call Transcript

electroCore Announces First Quarter 2024 Financial Results

May 8, 2024, 4:05 PM EDT - 9 months ago

electroCore Announces First Quarter 2024 Financial Results

electroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024

May 1, 2024, 8:04 AM EDT - 9 months ago

electroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024

Truvaga™ Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market Expansion

Apr 30, 2024, 8:00 AM EDT - 9 months ago

Truvaga™ Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market Expansion

electroCore Announces the Launch of Truvaga Plus® for General Wellness

Apr 8, 2024, 8:30 AM EDT - 10 months ago

electroCore Announces the Launch of Truvaga Plus® for General Wellness

electroCore Expands Intellectual Property Portfolio

Apr 2, 2024, 8:00 AM EDT - 10 months ago

electroCore Expands Intellectual Property Portfolio

electroCore, Inc. (ECOR) Q4 2023 Earnings Call Transcript

Mar 13, 2024, 8:15 PM EDT - 11 months ago

electroCore, Inc. (ECOR) Q4 2023 Earnings Call Transcript

electroCore Announces Fourth Quarter and Full Year 2023 Financial Results

Mar 13, 2024, 4:05 PM EDT - 11 months ago

electroCore Announces Fourth Quarter and Full Year 2023 Financial Results

electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024

Mar 5, 2024, 4:05 PM EST - 11 months ago

electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024

electroCore Expands Intellectual Property Portfolio for Nerve Stimulation Technology

Dec 12, 2023, 8:00 AM EST - 1 year ago

electroCore Expands Intellectual Property Portfolio for Nerve Stimulation Technology

Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023

Nov 15, 2023, 8:15 AM EST - 1 year ago

Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023

electroCore, Inc. (ECOR) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 10:27 PM EST - 1 year ago

electroCore, Inc. (ECOR) Q3 2023 Earnings Call Transcript

electroCore Announces Third Quarter 2023 Financial Results

Nov 8, 2023, 4:01 PM EST - 1 year ago

electroCore Announces Third Quarter 2023 Financial Results

electroCore to Participate in Canaccord Genuity's MedTech, Diagnostics and Digital Health & Services Forum

Nov 7, 2023, 8:00 AM EST - 1 year ago

electroCore to Participate in Canaccord Genuity's MedTech, Diagnostics and Digital Health & Services Forum

Data Highlighting Non-invasive Vagus Nerve Stimulation (nVNS) for Treatment of Symptoms of Gastroparesis Presented at 2023 American College of Gastroenterology Annual Meeting

Oct 24, 2023, 8:00 AM EDT - 1 year ago

Data Highlighting Non-invasive Vagus Nerve Stimulation (nVNS) for Treatment of Symptoms of Gastroparesis Presented at 2023 American College of Gastroenterology Annual Meeting

electroCore Announces Two-Year Extension of gammaCore™ Device Listing in the NHS Supply Chain Catalogue

Oct 17, 2023, 8:00 AM EDT - 1 year ago

electroCore Announces Two-Year Extension of gammaCore™ Device Listing in the NHS Supply Chain Catalogue

electroCore Expands Intellectual Property Portfolio for Non-Invasive Vagus Nerve Stimulation (nVNS) Technology

Oct 11, 2023, 8:00 AM EDT - 1 year ago

electroCore Expands Intellectual Property Portfolio for Non-Invasive Vagus Nerve Stimulation (nVNS) Technology

Data Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Neurological Injury Presented at 2023 World Stroke Congress

Oct 10, 2023, 8:00 AM EDT - 1 year ago

Data Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Neurological Injury Presented at 2023 World Stroke Congress

electroCore to Announce Third Quarter Financial Results on Wednesday, November 8

Oct 9, 2023, 8:00 AM EDT - 1 year ago

electroCore to Announce Third Quarter Financial Results on Wednesday, November 8

electroCore to Participate in the Lytham Partners Fall 2023 Virtual Investor Conference

Oct 5, 2023, 8:00 AM EDT - 1 year ago

electroCore to Participate in the Lytham Partners Fall 2023 Virtual Investor Conference

gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Improves Attention and Working Memory in Patients with Post Traumatic Stress Disorder (PTSD)

Sep 27, 2023, 8:00 AM EDT - 1 year ago

gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Improves Attention and Working Memory in Patients with Post Traumatic Stress Disorder (PTSD)

electroCore to Participate in the LD Micro Main Event XVI Conference

Sep 25, 2023, 8:00 AM EDT - 1 year ago

electroCore to Participate in the LD Micro Main Event XVI Conference

electroCore to Present at iAccess Alpha's – Top 10 Best Ideas from the Buyside Virtual Conference

Sep 21, 2023, 8:00 AM EDT - 1 year ago

electroCore to Present at iAccess Alpha's – Top 10 Best Ideas from the Buyside Virtual Conference

electroCore to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

Sep 7, 2023, 8:00 AM EDT - 1 year ago

electroCore to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

electroCore Announces Dismissal of All Litigation Related to Its 2018 Initial Public Offering

Aug 23, 2023, 8:00 AM EDT - 1 year ago

electroCore Announces Dismissal of All Litigation Related to Its 2018 Initial Public Offering

electroCore, Inc. (ECOR) Q2 2023 Earnings Call Transcript

Aug 9, 2023, 10:14 PM EDT - 1 year ago

electroCore, Inc. (ECOR) Q2 2023 Earnings Call Transcript

electroCore Announces Second Quarter 2023 Financial Results

Aug 9, 2023, 4:05 PM EDT - 1 year ago

electroCore Announces Second Quarter 2023 Financial Results

electroCore to Announce Second Quarter Financial Results on Wednesday, August 9

Aug 1, 2023, 8:00 AM EDT - 1 year ago

electroCore to Announce Second Quarter Financial Results on Wednesday, August 9

electroCore, Inc. Announces $8.145 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules

Jul 31, 2023, 9:29 AM EDT - 1 year ago

electroCore, Inc. Announces $8.145 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules

gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Improves Attention and Memory in Patients with Posttraumatic Stress Disorder (PTSD)

Jul 25, 2023, 8:00 AM EDT - 1 year ago

gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Improves Attention and Memory in Patients with Posttraumatic Stress Disorder (PTSD)

electroCore Expands Intellectual Patent Portfolio for nVNS Technology

Jul 18, 2023, 8:00 AM EDT - 1 year ago

electroCore Expands Intellectual Patent Portfolio for nVNS Technology

electroCore, Inc. Announces Distribution Agreement with Reliefband Technologies, LLC

Jul 13, 2023, 8:00 AM EDT - 1 year ago

electroCore, Inc. Announces Distribution Agreement with Reliefband Technologies, LLC

electroCore Provides Select Second Quarter 2023 Financial Guidance

Jul 11, 2023, 8:00 AM EDT - 1 year ago

electroCore Provides Select Second Quarter 2023 Financial Guidance

TAC-STIM™ Non-Invasive Vagal Nerve Stimulation Selected for Inclusion in the Air Force Research Laboratories Real-Time Assessing and Augmenting Cognitive Performance in Extreme Environments Project

Jun 27, 2023, 8:00 AM EDT - 1 year ago

TAC-STIM™ Non-Invasive Vagal Nerve Stimulation Selected for Inclusion in the Air Force Research Laboratories Real-Time Assessing and Augmenting Cognitive Performance in Extreme Environments Project